Literature DB >> 1519134

Detection of Chlamydia pneumoniae in coronary arterial fatty streaks and atheromatous plaques.

A Shor1, C C Kuo, D L Patton.   

Abstract

There is serological evidence that a recently described new strain of Chlamydia, namely Chlamydia pneumoniae TWAR, is associated with coronary artery disease. This study describes the detection of TWAR organisms in the coronary arterial fatty streaks and atheromatous plaques in 7 autopsy cases. TWAR-like organisms were observed ultrastructurally in the lipid-rich core area of fibrolipid plaques and in intimal smooth-muscle cells. In 5 cases, immunoperoxidase staining showed positive reactions to Chlamydia genus- and C. pneumoniae species-specific monoclonal antibodies.

Entities:  

Mesh:

Year:  1992        PMID: 1519134

Source DB:  PubMed          Journal:  S Afr Med J


  75 in total

Review 1.  Chlamydia pneumoniae in arteries: the facts, their interpretation, and future studies.

Authors:  D Taylor-Robinson; B J Thomas
Journal:  J Clin Pathol       Date:  1998-11       Impact factor: 3.411

Review 2.  Chlamydia pneumoniae and atherosclerosis: critical assessment of diagnostic methods and relevance to treatment studies.

Authors:  Jens Boman; Margaret R Hammerschlag
Journal:  Clin Microbiol Rev       Date:  2002-01       Impact factor: 26.132

3.  Chlamydia pneumoniae, the Heart, and Coronary Artery Disease: Is There a Cause and Effect Relationship?

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-06       Impact factor: 3.725

4.  Specificity of detection of Chlamydia pneumoniae in cardiovascular atheroma: evaluation of the innocent bystander hypothesis.

Authors:  L A Jackson; L A Campbell; R A Schmidt; C C Kuo; A L Cappuccio; M J Lee; J T Grayston
Journal:  Am J Pathol       Date:  1997-05       Impact factor: 4.307

5.  Cytokines induce indoleamine 2,3-dioxygenase expression in human atheroma-asociated cells: implications for persistent Chlamydophila pneumoniae infection.

Authors:  Jessica B Sakash; Gerald I Byrne; Andrew Lichtman; Peter Libby
Journal:  Infect Immun       Date:  2002-07       Impact factor: 3.441

6.  Failure to detect Chlamydia pneumoniae by cell culture and polymerase chain reaction in major arteries of 93 patients with atherosclerosis.

Authors:  J Bishara; S Pitlik; A Kazakov; G Sahar; M Haddad; A Vojdani; S Rosenberg; Z Samra
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-05-09       Impact factor: 3.267

7.  Association between Chlamydia pneumoniae IgG antibodies and migraine.

Authors:  QiHong Lu; Jinzh Xu; HongYan Liu
Journal:  J Headache Pain       Date:  2009-02-24       Impact factor: 7.277

8.  A Novel ASK Inhibitor AGI-1067 Inhibits TLR-4-Mediated Activation of ASK1 by Preventing Dissociation of Thioredoxin from ASK1.

Authors:  Shuhui Zheng; Lingli Long; Yonghao Li; Yuxia Xu; Zhang Jiqin; Weidong Ji; Wang Min
Journal:  Cardiovasc Pharm Open Access       Date:  2015-02-26

9.  Influence of clarithromycin on early atherosclerotic lesions after Chlamydia pneumoniae infection in a rabbit model.

Authors:  Ignatius W Fong; Brian Chiu; Esther Viira; Dan Jang; James B Mahony
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

10.  Chlamydophila pneumoniae infection leads to smooth muscle cell proliferation and thickening in the coronary artery without contributions from a host immune response.

Authors:  Justin F Deniset; Paul K M Cheung; Elena Dibrov; Kaitlin Lee; Sarah Steigerwald; Grant N Pierce
Journal:  Am J Pathol       Date:  2009-12-17       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.